Key Predictors of Inpatient Mortality in COVID-19 Patients

Pavankumar Kamat


July 14, 2021


  • The presence of hypertension and diabetes together was associated with a significantly increased risk of inpatient COVID-19 mortality.

  • Furthermore, advanced age (>65 years), male sex, hypertension and cerebrovascular disease were independently associated with an increased risk of inpatient mortality, irrespective of ethnicity or high social deprivation scores.

Why this matters

  • Findings will help focus clinical attention on all high-risk patients with COVID-19 admitted to the hospital, particularly those with hypertension with or without associated diabetes.

Study design

  • A retrospective, single-center study included 907 patients with COVID-19 (age, >17 years) who were admitted to the hospital between March and May 2020.

  • Funding: Sandwell and West Birmingham National Health Service Trust Research and Development Department.

Key results

  • 60.2% of the patients survived.

  • The presence of diabetes and hypertension together was associated with a greater risk of COVID-19 mortality (OR, 2.75; 95% CI, 1.80-4.21; P<.001) vs hypertension alone (OR, 1.95; 95% CI, 1.26-3.02; P=.003) and diabetes alone (OR, 1.28; 95% CI, 0.66-2.48; P=.463).

  • Advanced age (OR, 3.32; 95% CI, 2.15-5.11), male gender (OR, 2.04; 95% CI, 1.47-2.82), hypertension (OR, 1.69; 95% CI, 1.10-2.61) and cerebrovascular disease (OR, 1.87; 95% CI, 1.31-2.68) were independently associated with an increased risk of mortality.

  • The mortality risk did not differ between the different quintiles of ethnicity and social deprivation.

  • Among biomarkers, high-sensitivity troponin I was the best predictor of mortality (OR, 4.43; 95% CI, 3.10-7.10).

  • Angiotensin-receptor blockers (OR, 0.57; 95% CI, 0.33-0.96) and angiotensin-converting enzyme inhibitors (OR, 0.65; 95% CI, 0.43-0.97) were not associated with adverse outcomes.


  • Retrospective design.


Basu A, Agwu JC, Barlow N, Lee B. Hypertension is the major predictor of poor outcomes among inpatients with COVID-19 infection in the UK: a retrospective cohort study. BMJ Open. 2021;11(6):e047561. doi: 10.1136/bmjopen-2020-047561. PMID: 34172549.  View full text

This clinical summary originally appeared on Univadis, part of the Medscape Professional Network.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: